Lockheed Martin Today
LMT
Lockheed Martin
$604.87 +14.96 (+2.54%) As of 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more. - 52-Week Range
- $437.25
▼
$692.00 - Dividend Yield
- 2.28%
- P/E Ratio
- 22.30
- Price Target
- $632.33
Lockheed Martin NYSE: LMT reported
third-quarter results on Thursday, Oct. 22, and on paper, there was little to complain about. Earnings came in at $7.97 per share, well ahead of the $7.52 analysts expected, while revenue climbed 11.3% over the prior year to $20.7 billion.
Management also raised its outlook for the second straight quarter. Lockheed now expects 2026 sales of about $80 billion to $82 billion, up from $79.75 billion to $81.75 billion, and earnings per share of roughly $30.35-$30.75, up from $29.95-$30.65. The immediate reaction following the stellar report? Shares closed up nearly 7% on the day, and trading back above the stock's key 200-day moving average.
It's the latest in a busy week of defense earnings, following RTX NYSE: RTX and Northrop Grumman NYSE: NOC. But Lockheed's story isn’t just about beating the topline. The market, and many investors, will now be asking: with a record $292 billion backlog, how quickly can those orders turn into delivered products and, ultimately, cash?
Where the Backlog Growth Actually Came From
The headline backlog figure of $292 billion is up 27% from the prior quarter. But the growth has been anything but even.
Almost all of it came from one segment. Missiles and Fire Control, home to the PAC-3 and THAAD interceptor programs, saw its backlog jump to about $142.5 billion from $46.7 billion at the start of the year. That figure includes $52.5 billion tied to a multi-year award to produce PAC-3 MSE interceptors. Aeronautics, which houses the F-35, actually moved the other way, with backlog slipping to $57.3 billion from $59.4 billion.
In other words, the record backlog is now largely a missile defense story. That matters for conversion. At the segment's current sales pace, Missiles and Fire Control has more than eight years of work, and those orders become revenue only as interceptors are built and delivered.
Production and Delivery Timing
Encouraging signs are emerging on that front, though. Missiles and Fire Control sales rose 24% in the quarter, driven by production ramps on PAC-3 and THAAD, along with GMLRS and the Precision Strike Missile.
The aircraft side is a bit messier. Lockheed delivered 43 F-35s in the quarter, down from 46 a year earlier, and 94 through nine months versus 143 last year. More importantly, the company said its spending on the F-35 Lot 20 advance contract has now outrun what the government has authorized and funded so far. Talks on Lots 20 and beyond are ongoing, and Lockheed warned that results and cash flow will take a hit in future periods if that funding doesn't come through.
Cash Flow, Margins, and Capital Returns
Lockheed Martin MarketRank™ Stock Analysis
4.392956441145 of 5 stars- Overall MarketRank™
- 88th Percentile
- Analyst Rating
- Moderate Buy
- Upside/Downside
- 4.5% Upside
- Short Interest Level
- Healthy
- Dividend Strength
- Strong
- News Sentiment
- 0.73

- Insider Trading
- N/A
- Proj. Earnings Growth
- 8.48%
See Full AnalysisFree cash flow came in at
$3 billion for the quarter, down from $3.3 billion a year ago. But over nine months, free cash flow rose to $5.6 billion from $4.2 billion, and the full-year outlook rose to about $7.8 billion to $8.0 billion from $7.0 billion to $7.2 billion.
One line worth watching is contract assets, which climbed to about $16.9 billion from $13 billion at year-end. That's work Lockheed has already recognized as revenue but hasn't yet billed, a sign that cash is lagging behind reported sales as production ramps up.
Margins were fairly steady, with segment operating margin at 10.8% versus 10.9% a year ago. Still, Lockheed's own filing flags fixed-price contracts, where the company absorbs cost overruns, as a key risk, and the quarter showed that risk in small doses. Aeronautics margin slipped to 9.0% due to unfavorable profit adjustments on the F-16 and C-130, while Rotary and Mission Systems adjusted for its Heavy Lift and Seahawk programs. Importantly, it has had no reach-forward losses so far this year, compared with $1.6 billion in the same period of 2025.
What Could Speed Up or Slow Down Conversion
The supportive and bullish case for LMT is clear. A missile defense backlog this size, production ramps already lifting sales, higher cash flow guidance, and no major program losses give Lockheed unusual visibility. Suppliers like Karman NYSE: KRMN are already landing multi-year Lockheed contracts tied to missile defense, a sign the ramp is moving through the supply chain.
The risks now sit mostly in execution. Scaling interceptor output depends on suppliers keeping pace, and Lockheed's filing specifically names materials such as rare earth minerals and microelectronics as potential constraints. Rising contract assets could keep cash trailing sales, and the unresolved F-35 Lot 20 talks remain a clear overhang. The backlog is built. Turning it into cash is the part worth watching closely now.
Before you consider Lockheed Martin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lockheed Martin wasn't on the list.
While Lockheed Martin currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.